CoChat

Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy

Hashimoto, Yasumasa, Kuniishi, Hiroshi, Sakai, Kazuhisa, Fukushima, Yuta, Du, Xuan, Yamashiro, Kunihiko, Hori, Kei, Imamura, Michihiro, Hoshino, Mikio, Yamada, Mitsuhiko, Araki, Toshiyuki, Sakagami, Hiroyuki, Takeda, Shin’ichi, Itaka, Keiji, Ichinohe, Noritaka, Muntoni, Francesco, Sekiguchi, Masayuki, Aoki, Yoshitsugu · 2022 · Progress in Neurobiology
Cited by 51

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2022.102288

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 77

  1. Alter, 2006, Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology, Nat. Med., 12, 175, 10.1038/nm1345 · DOI · Paper page
  2. Alter, 2006, Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology, Nat. Med., 12, 175, 10.1038/nm1345 · DOI · Paper page
  3. Amaral, 2008, Neuroanatomy of autism, Trends Neurosci., 31, 137, 10.1016/j.tins.2007.12.005 · DOI · Paper page
  4. Aoki, 2010, In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse, Mol. Ther., 18, 1995, 10.1038/mt.2010.186 · DOI
  5. Aoki, 2010, In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse, Mol. Ther., 18, 1995, 10.1038/mt.2010.186 · DOI
  6. Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem. Biophys. Res. Commun., 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
  7. Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem. Biophys. Res. Commun., 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
  8. Aranmolate, 2017, Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy, BMC Neurosci., 18, 63, 10.1186/s12868-017-0381-0 · DOI
  9. Aranmolate, 2017, Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy, BMC Neurosci., 18, 63, 10.1186/s12868-017-0381-0 · DOI
  10. Araque, 2014, Gliotransmitters travel in time and space, Neuron, 81, 728, 10.1016/j.neuron.2014.02.007 · DOI · Paper page
  11. Bardoni, 2000, Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies, Neuromuscul. Disord., 10, 194, 10.1016/S0960-8966(99)00108-X · DOI
  12. Bardoni, 2000, Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies, Neuromuscul. Disord., 10, 194, 10.1016/S0960-8966(99)00108-X · DOI
  13. Baron-Cohen, 2000, The amygdala theory of autism, Neurosci. Biobehav. Rev., 24, 355, 10.1016/S0149-7634(00)00011-7 · DOI · Paper page
  14. Benson, 2001, Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain, J. Biol. Chem., 276, 24232, 10.1074/jbc.M010418200 · DOI · Paper page
  15. Berg, 2018, Developmental social communication deficits in the Shank3 rat model of phelan-mcdermid syndrome and autism spectrum disorder, Autism Res., 11, 587, 10.1002/aur.1925 · DOI · Paper page
  16. Bezzi, 2004, Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate, Nat. Neurosci., 7, 613, 10.1038/nn1246 · DOI · Paper page
  17. Blake, 1998, beta-dystrobrevin, a member of the dystrophin-related protein family, Proc. Natl. Acad. Sci. U.S.A., 95, 241, 10.1073/pnas.95.1.241 · DOI · Paper page
  18. Blake, 1999, Different dystrophin-like complexes are expressed in neurons and glia, J. Cell Biol., 147, 645, 10.1083/jcb.147.3.645 · DOI · Paper page
  19. Bresolin, 1994, Cognitive impairment in Duchenne muscular dystrophy, Neuromuscul. Disord., 4, 359, 10.1016/0960-8966(94)90072-8 · DOI · Paper page
  20. Caudal, 2020, Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model, PLoS One, 15, 10.1371/journal.pone.0230083 · DOI · Paper page
  21. Chamova, 2013, Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies, Balk. J. Med. Genet., 16, 21, 10.2478/bjmg-2013-0014 · DOI · Paper page
  22. Chaussenot, 2019, Dp71-dystrophin deficiency alters prefrontal cortex excitation-inhibition balance and executive functions, Mol. Neurobiol., 56, 2670, 10.1007/s12035-018-1259-6 · DOI · Paper page
  23. Chelly, 1988, Transcription of the dystrophin gene in human muscle and non-muscle tissue, Nature, 333, 858, 10.1038/333858a0 · DOI · Paper page
  24. Clemens, 2020, Safety, tolerability, and efficacy of viltolarsen in boys with duchenne muscular dystrophy amenable to exon 53 skipping: a phase 2 randomized clinical trial, JAMA Neurol., 77, 982, 10.1001/jamaneurol.2020.1264 · DOI · Paper page
  25. De Camilli, 1983, Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections, J. Cell Biol., 96, 1337, 10.1083/jcb.96.5.1337 · DOI · Paper page
  26. Doorenweerd, 2014, Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy, Ann. Neurol., 76, 403, 10.1002/ana.24222 · DOI · Paper page
  27. Doorenweerd, 2017, Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy, Sci. Rep., 7, 12575, 10.1038/s41598-017-12981-5 · DOI · Paper page
  28. Dunah, 2001, Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane, J. Neurosci., 21, 5546, 10.1523/JNEUROSCI.21-15-05546.2001 · DOI · Paper page
  29. Felisari, 2000, Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy, Neurology, 55, 559, 10.1212/WNL.55.4.559 · DOI
  30. Felix-Ortiz, 2016, Bidirectional modulation of anxiety-related and social behaviors by amygdala projections to the medial prefrontal cortex, Neuroscience, 321, 197, 10.1016/j.neuroscience.2015.07.041 · DOI · Paper page
  31. Filippo, 2012, Psychological aspects in children affected by duchenne de boulogne muscular dystrophy, Ment. Illn., 4
  32. Frank, 2020, Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy, Neurology, 94, e2270, 10.1212/WNL.0000000000009233 · DOI · Paper page
  33. Fremeau, 2004, Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites, Science, 304, 1815, 10.1126/science.1097468 · DOI · Paper page
  34. Frésard, 2012, Fine mapping of complex traits in non-model species: using next generation sequencing and advanced intercross lines in Japanese quail, BMC Genom., 13, 551, 10.1186/1471-2164-13-551 · DOI
  35. Fujino, 2018, Autism spectrum disorders are prevalent among patients with dystrophinopathies, Neurol. Sci., 39, 1279, 10.1007/s10072-018-3341-2 · doi:10.1007/s10072-018-3341-2
  36. Fukushima, 2021, Treatment of ischemic neuronal death by introducing brain-derived neurotrophic factor mRNA using polyplex nanomicelle, Biomaterials, 270, 10.1016/j.biomaterials.2021.120681 · DOI
  37. Greenberg, 1996, Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71, Hum. Mol. Genet., 5, 1299, 10.1093/hmg/5.9.1299 · DOI
  38. Hansel, 2019, Deregulation of synaptic plasticity in autism, Neurosci. Lett., 688, 58, 10.1016/j.neulet.2018.02.003 · DOI · Paper page
  39. Heise, 2016, Selective Localization of Shanks to VGLUT1-Positive Excitatory Synapses in the Mouse Hippocampus, Front. Cell Neurosci., 10, 106, 10.3389/fncel.2016.00106 · DOI · Paper page
  40. Hendriksen, 2008, Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder, J. Child Neurol., 23, 477, 10.1177/0883073807309775 · DOI · Paper page
  41. Hinton, 2009, Association of autistic spectrum disorders with dystrophinopathies, Pedia Neurol., 41, 339, 10.1016/j.pediatrneurol.2009.05.011 · DOI
  42. Hoffman, 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4 · DOI · Paper page
  43. Hori, 2020, AUTS2 Regulation of Synapses for Proper Synaptic Inputs and Social Communication, iScience, 23, 10.1016/j.isci.2020.101183 · DOI
  44. Huang, 2020, Social Behavior Is Modulated by Valence-Encoding mPFC-Amygdala Sub-circuitry, Cell Rep., 32, 10.1016/j.celrep.2020.107899 · DOI · Paper page
  45. John, A., Ng-Cordell, E., Hanna, N., Brkic, D., Baker, K., 2020. The neurodevelopmental spectrum of synaptic vesicle cycling disorders. J Neurochem. · DOI
  46. Kanayama, 2006, A PEG-based biocompatible block catiomer with high buffering capacity for the construction of polyplex micelles showing efficient gene transfer toward primary cells, ChemMedChem, 1, 439, 10.1002/cmdc.200600008 · DOI · Paper page
  47. Knuesel, 1999, Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice), Eur. J. Neurosci., 11, 4457, 10.1046/j.1460-9568.1999.00887.x · DOI · Paper page
  48. Komaki, 2018, Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy, Sci. Transl. Med., 10
  49. Komoto, 1984, Infantile autism and Duchenne muscular dystrophy, J. Autism Dev. Disord., 14, 191, 10.1007/BF02409661 · DOI
  50. Kueh, 2011, Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse, Neurobiol. Dis., 43, 558, 10.1016/j.nbd.2011.05.002 · DOI
  51. Lidov, 1990, Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons, Nature, 348, 725, 10.1038/348725a0 · DOI · Paper page
  52. Lidov, 1995, Dp140: a novel 140 kDa CNS transcript from the dystrophin locus, Hum. Mol. Genet., 4, 329, 10.1093/hmg/4.3.329 · DOI · Paper page
  53. Miranda, 2011, Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71, Neurobiol. Dis., 43, 134, 10.1016/j.nbd.2011.02.017 · DOI
  54. Miranda, 2015, Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy, Mol. Autism, 6, 60, 10.1186/s13229-015-0053-9 · DOI · Paper page
  55. Mizuno, 1993, Distribution of dystrophin isoforms and dystrophin-associated proteins 43DAG (A3a) and 50DAG (A2) in various monkey tissues, J. Biochem., 114, 936, 10.1093/oxfordjournals.jbchem.a124281 · DOI
  56. Moukhles, 2001, Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain, J. Neurochem., 78, 824, 10.1046/j.1471-4159.2001.00466.x · doi:10.1046/j.1471-4159.2001.00466.x
  57. Muntoni, 2003, Dystrophin and mutations: one gene, several proteins, multiple phenotypes, Lancet Neurol., 2, 731, 10.1016/S1474-4422(03)00585-4 · DOI · Paper page
  58. Nogami, 2021, Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice, Hum. Mol. Genet., 30, 1006, 10.1093/hmg/ddab100 · DOI
  59. Nonneman, 2012, A defect in dystrophin causes a novel porcine stress syndrome, BMC Genom., 13, 233, 10.1186/1471-2164-13-233 · DOI
  60. Pane, 2012, Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation, J. Pedia, 161
  61. Patel, 2019, Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes, Transl. Psychiatry, 9, 200, 10.1038/s41398-019-0535-1 · DOI
  62. Razzoli, 2020, Social stress is lethal in the mdx model of Duchenne muscular dystrophy, EBioMedicine, 55, 10.1016/j.ebiom.2020.102700 · DOI · Paper page
  63. Ricotti, 2016, Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev. Med. Child Neurol., 58, 77, 10.1111/dmcn.12922 · DOI · Paper page
  64. Roccella, 2003, Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy, Minerva Pedia, 55
  65. Romo-Yáñez, 2020, Characterization of the expression of dystrophins and dystrophin-associated proteins during embryonic neural stem/progenitor cell differentiation, Neurosci. Lett., 736, 10.1016/j.neulet.2020.135247 · doi:10.1016/j.neulet.2020.135247
  66. Saggu, 2013, Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice, Schizophr. Res., 146, 254, 10.1016/j.schres.2013.01.037 · DOI
  67. Scaglioni, 2021, The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy, Acta Neuropathol. Commun., 9, 7, 10.1186/s40478-020-01106-1 · DOI
  68. Sekiguchi, 2009, A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice, Brain, 132, 124, 10.1093/brain/awn253 · DOI · Paper page
  69. Tachibana, 2014, Semi-automatic classification of birdsong elements using a linear support vector machine, PLoS One, 9, 10.1371/journal.pone.0092584 · DOI
  70. Talbot, 2006, Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin, Hum. Mol. Genet., 15, 3041, 10.1093/hmg/ddl246 · DOI · Paper page
  71. Tozawa, 2012, The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain, Mol. Neurobiol., 45, 287, 10.1007/s12035-012-8233-5 · DOI
  72. Uchida, 2013, In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle, PLoS One, 8, 10.1371/journal.pone.0056220 · DOI · Paper page
  73. Vaillend, 2017, Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice, Hum. Mol. Genet., 26, 1041
  74. Waite, 2012, The dystrophin-glycoprotein complex in brain development and disease, Trends Neurosci., 35, 487, 10.1016/j.tins.2012.04.004 · DOI · Paper page
  75. Wicksell, 2004, Specific cognitive deficits are common in children with Duchenne muscular dystrophy, Dev. Med. Child Neurol., 46, 154, 10.1111/j.1469-8749.2004.tb00466.x · DOI
  76. Yamamoto, 2010, Reduction of abnormal behavioral response to brief restraint by information from other mice in dystrophin-deficient mdx mice, Neuromuscul. Disord., 20, 505, 10.1016/j.nmd.2010.05.006 · DOI · Paper page
  77. Zucker, 2002, Short-term synaptic plasticity, Annu. Rev. Physiol., 64, 355, 10.1146/annurev.physiol.64.092501.114547 · DOI · Paper page

Cited by

See all 51

Metadata

Authors
Hashimoto, Y., Kuniishi, H., Sakai, K., Fukushima, Y., Du, X., Yamashiro, K., Hori, K., Imamura, M., Hoshino, M., Yamada, M., Araki, T., Sakagami, H., Takeda, S., Itaka, K., Ichinohe, N., Muntoni, F., Sekiguchi, M., & Aoki, Y.
Venue
Progress in Neurobiology
Publisher
Elsevier BV
Published
2022-09
Volume
216
Pages
102288
ISSN
0301-0082
Cited by
51
References
13
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy. https://app.cochat.ai/papers/10.1016/j.pneurobio.2022.102288
The paper
Hashimoto, Y., Kuniishi, H., Sakai, K., Fukushima, Y., Du, X., Yamashiro, K., Hori, K., Imamura, M., Hoshino, M., Yamada, M., Araki, T., Sakagami, H., Takeda, S., Itaka, K., Ichinohe, N., Muntoni, F., Sekiguchi, M., & Aoki, Y. (2022). Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy. Progress in Neurobiology. https://doi.org/10.1016/j.pneurobio.2022.102288

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.